Skip to main content
    Educational content — not medical advice. Information on this page is for educational purposes only and is not a substitute for advice from a licensed physician. GLP-1 medications carry meaningful risks; speak with your doctor before starting any treatment. Compounded GLP-1 medications are not FDA-approved and clinical evidence is less robust than for FDA-approved branded products (Wegovy, Zepbound, Ozempic, Mounjaro). Read our full medical disclaimer · FDA on compounded GLP-1.
    Naming ClarityUpdated May 2026

    Quick Answer

    Semaglutide is Wegovy. They are the same molecule.

    “Semaglutide vs Wegovy” is like “ibuprofen vs Advil.” Semaglutide is the generic drug name; Wegovy is Novo Nordisk's brand name for it. The real comparison most people are searching for is branded Wegovy (~$1,300–$1,400/mo) versus compounded semaglutide ($99–$249/mo) from telehealth providers.

    Semaglutide vs Wegovy 2026: Same Drug, Very Different Prices

    Wegovy, Ozempic, Rybelsus, and compounded semaglutide all contain the same active molecule: semaglutide. Here's what separates them — indications, dosing, formulation, cost, and why compounded is dramatically cheaper.

    4

    Semaglutide products on the market

    ~$1,350

    Avg. monthly cost of branded Wegovy

    $99

    Starting price for compounded semaglutide

    Why Do People Search “Semaglutide vs Wegovy”?

    There are two main reasons:

    1. Naming confusion

    Patients see “semaglutide” on generic drug information sites and “Wegovy” on insurance forms and ads. They're not sure if they're the same thing. They are. Semaglutide is the molecule; Wegovy is one of the four branded products containing it.

    2. Searching for a cheaper alternative to Wegovy

    Many patients find out that branded Wegovy costs $1,300+ per month without insurance and start searching for alternatives. “Semaglutide” in search context often means “compounded semaglutide,” which is the same active ingredient at a fraction of the cost through licensed telehealth providers.

    All Semaglutide Products Compared

    All four are semaglutide. What differs: indication, formulation, dose, and price. Pricing verified May 2026.

    ProductIndicationMax doseRoutePrice (no ins.)FDA-approved
    WegovyObesity / weight management2.4 mg weeklySubQ injection~$1,300–$1,400/mo Yes
    OzempicType 2 diabetes (off-label: weight loss)2 mg weeklySubQ injection~$900–$1,000/mo Yes
    RybelsusType 2 diabetes14 mg dailyOral tablet~$900–$1,000/mo Yes
    Compounded semaglutide(best value)Weight loss / obesity (with prescription)Flexible (custom)SubQ injection (vial)$99–$249/mo No (503A compounded)

    Branded prices are full retail cash prices without insurance or manufacturer savings programs. Compounded pricing is through verified telehealth providers.

    Why Is Compounded Semaglutide So Much Cheaper Than Wegovy?

    The branded Wegovy price (~$1,350/mo) includes:

    • Novo Nordisk's multi-billion dollar R&D cost recovery (STEP trials alone cost hundreds of millions)
    • The proprietary FlexTouch auto-injector pen device
    • Brand marketing, sales force, and direct-to-consumer advertising
    • FDA-regulated GMP manufacturing at Novo Nordisk facilities
    • The regulatory approval infrastructure and ongoing post-market studies

    Compounded semaglutide from a licensed 503A pharmacy includes:

    • The active ingredient: semaglutide
    • A sterile bacteriostatic water or saline diluent
    • Standard pharmacy compounding overhead
    • Telehealth provider markup and physician review

    Important: Compounded semaglutide is not FDA-approved as a finished drug product. It's produced under the 503A pharmacy compounding exemption, which allows licensed pharmacies to compound drugs for specific patients with a valid prescription. The active molecule is the same; the manufacturing oversight framework is different from branded Wegovy.

    Compounded Semaglutide Providers: What Wegovy Costs vs. Alternatives

    Pricing verified May 2026. All require a valid prescription from a licensed prescriber.

    12-month cost comparison

    $16,200

    Branded Wegovy
    (full retail/yr)

    $1,188

    Strut Health
    ($99/mo × 12)

    $1,896

    TMates
    ($158/mo × 12)

    $2,748

    Eden Health
    ($229/mo × 12)

    Savings vs. branded Wegovy: $15,012 – $14,304/year depending on provider.

    Best Value

    Strut Health

    Verified on brand site Invalid Date
    • Compounded injectable semaglutide from $99/mo
    • Vial format — custom dose flexibility
    • Physician review included
    Start at Strut

    TMates

    Verified on brand site Invalid Date
    • Compounded semaglutide from $158/mo
    • Physician-supervised titration
    • Ongoing provider access for adjustments
    Visit TMates

    Embody Health

    Verified on brand site Invalid Date
    • $149 first month promotional pricing
    • Compounded injectable semaglutide
    • Physician review and prescription included
    Visit Embody

    Eden Health

    Verified on brand site Invalid Date
    • Compounded semaglutide from $229/mo
    • Established telehealth provider
    • Physician-supervised weight management program
    Visit Eden

    How this page is reviewed

    Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).

    Last editorially reviewed
    Invalid Date

    Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.

    If you are considering a GLP-1 medication: consult a licensed physician familiar with your medical history. Do not start, stop, or change a prescription based on content from this site. Side effects, contraindications, and drug interactions are real and individual.

    Frequently Asked Questions

    Is semaglutide the same as Wegovy?

    Yes. Semaglutide is the International Nonproprietary Name (INN) — the official generic name of the active drug molecule. Wegovy is Novo Nordisk's brand name for semaglutide when prescribed and indicated for chronic weight management in adults with obesity or overweight. They are the same molecule. Calling it "semaglutide vs Wegovy" is like saying "ibuprofen vs Advil" — one is the generic name, one is the brand name of the same drug.

    Why is compounded semaglutide cheaper than Wegovy?

    Branded Wegovy costs ~$1,300–$1,400/month at full retail because the price includes Novo Nordisk's R&D cost recovery, brand marketing, the proprietary auto-injector pen device, GMP manufacturing overhead, and regulatory approval costs. Compounded semaglutide is produced by licensed 503A pharmacy compounders who source the active ingredient and mix it without the brand markup, device engineering, or pharmaceutical pricing structure. The active molecule is the same; the price reflects everything around it.

    Is Ozempic the same as Wegovy?

    Yes — both Ozempic and Wegovy contain semaglutide as the active ingredient. The difference is the FDA-approved indication and maximum dose: Ozempic is approved for Type 2 diabetes management (doses up to 2mg weekly); Wegovy is approved for chronic weight management in adults with obesity or overweight (doses up to 2.4mg weekly). Ozempic is sometimes prescribed off-label for weight loss, but its maximum approved dose (2mg) is slightly lower than Wegovy's maximum (2.4mg).

    Can I use Ozempic for weight loss?

    Ozempic is not FDA-approved for weight loss — it's approved for Type 2 diabetes. However, it contains the same active ingredient (semaglutide) that produces weight loss. Some physicians prescribe it off-label for weight management in patients without diabetes, particularly when Wegovy is unavailable or unaffordable. Off-label prescribing is legal and at the physician's clinical judgment. Wegovy is the FDA-approved weight-loss version of semaglutide; Ozempic is the diabetes version.

    What's the difference between Wegovy and Rybelsus?

    Both Wegovy and Rybelsus contain semaglutide, but they are different formulations for different routes of administration. Wegovy is a once-weekly subcutaneous injection (the same route as Ozempic) at doses up to 2.4mg, FDA-approved for weight management. Rybelsus is a once-daily oral tablet at doses of 3mg, 7mg, or 14mg, FDA-approved for Type 2 diabetes. The oral bioavailability of semaglutide is much lower than injection — the 14mg daily oral dose is roughly equivalent in effect to lower injectable doses. Rybelsus is not approved for weight loss.

    Is compounded semaglutide as effective as Wegovy?

    The active molecule is identical — semaglutide in both cases. There are no head-to-head clinical trials comparing compounded and branded semaglutide efficacy because they are legally distinct products (compounded drugs are not FDA-approved as such). Branded Wegovy is manufactured under FDA-regulated GMP facilities with rigorous quality controls. Compounded semaglutide is produced by 503A pharmacy compounders under different oversight standards. If manufacturing certainty and regulatory status are primary concerns, branded Wegovy provides those guarantees. If cost is the primary driver, compounded semaglutide from a licensed 503A pharmacy offers the same active ingredient at a fraction of the price.

    Related Pages

    glp1comparehub

    Your independent guide to comparing GLP-1 medication providers. Find the right telehealth program for your weight-loss journey.

    Independent & Unbiased

    Medical Disclaimer: The information on this website is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any medication or treatment program. GLP-1 medications require a prescription and should only be used under medical supervision.

    Affiliate Disclosure: GLP1CompareHub.com is an independent review site. We may earn a commission when you click our links — at no additional cost to you. Our editorial recommendations are not influenced by commission rates. See our full affiliate disclosure.

    Compounded GLP-1 Notice: Compounded medications (compounded semaglutide, compounded tirzepatide) are NOT FDA-approved. They are produced by state-licensed 503A and 503B compounding pharmacies under specific FDA exemptions. Consult your prescriber about whether a branded FDA-approved medication or a compounded alternative is right for you.

    © 2026 GLP1CompareHub.com. All rights reserved.

    Semaglutide vs Wegovy 2026: Same Drug, Very Different Prices | GLP1CompareHub